Bestatin induces specific changes in Trypanosoma cruzi dipeptide pool.
Antimicrob Agents Chemother
; 59(5): 2921-5, 2015 May.
Article
en En
| MEDLINE
| ID: mdl-25712359
Proteases and peptidases in Trypanosoma cruzi are considered potential targets for antichagasic chemotherapy. We monitored changes in low-mass metabolites in T. cruzi epimastigotes treated with bestatin, a dipeptide metalloaminopeptidase inhibitor. After treatment, multiple dipeptides were shown to be increased, confirming in situ inhibition of the leucine aminopeptidase of T. cruzi (LAPTc) and probably other peptidases.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Trypanosoma cruzi
/
Dipéptidos
/
Leucina
Idioma:
En
Revista:
Antimicrob Agents Chemother
Año:
2015
Tipo del documento:
Article
Pais de publicación:
Estados Unidos